Publication | Closed Access

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study

Adjuvant CarboplatinVersus SixMedicinePhase Iii TrialGynecologyCancer TreatmentOncologyRadiation OncologyGynecology OncologyMolecular OncologyEndocrine-related CancerOvarian Cancer